Sodium Hypochlorite Inclusion In Antiseptic Drug TFM Sought By Alcavis
This article was originally published in The Tan Sheet
Executive Summary
Sodium hypochlorite .05% to .5% should be classified as safe and effective in the OTC Tentative Final Monograph for Healthcare Antiseptic Drug Products, Alcavis International says in a Feb. 20 citizen petition
You may also be interested in...
Triclosan Efficacy Studies Support “Significant” Antimicrobial Effect – Ciba
New in vitro and in vivo studies on triclosan "substantially augment" the evidence supporting Category I status for the antimicrobial ingredient, Ciba Specialty Chemicals maintains in a Feb. 11 citizen petition to FDA
Triclosan Antiseptic Category I Status Requested By CIBA
FDA should consider new safety data supporting Category I (safe and effective) status for triclosan in the OTC Tentative Final Monograph for Health Care Antiseptic Drug Products, CIBA Specialty Chemicals and an alliance of six triclosan manufacturers/marketers state in a Sept. 13 citizen petition.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC